• Patent Grants
  • Patents which prove CHA Medical Group’s strength in stem cell research

CHA Medical Group’s advanced stem cell technology

CHA Medical Group has filed the following patents related to stem cell and immunocyte research.

No Patent Grants
51 [KR] Wound-healing composition for external use and cosmetic composition containing rice cell-derived recombinant human granulocyte macrophage-colony stimulating factor
50 [JP] Method and composition for proliferating of natural killer cell (Registration number 06073417)
49 [KR] Method for proliferating neuronal progenitor cells and composition for treating nervous diseases comprising the neuronal progenitor cells (Registration number 10-1662792)
48 [AU] Process for differentiation of human neural progenitor cells to dopaminergic neurons and medium for differentiation thereof (Registration number 2011265956)
47 [KR] Methods for cell expansion and uses of cells and conditioned media produced thereby for therapy (Registration number 10-1602951)
46 [KR] Methods for cell expansion and uses of cells and conditioned media produced thereby for therapy (Registration number 10-1569204)
45 [KR] Methods for cell expansion and uses of cells and conditioned media produced thereby for therapy (Registration number 10-1557256)
44 [JP] Process for differentiation of human neural progenitor cells to dopaminergic neurons and medium for differentiation thereof (Registration number 05776101)
43 [KR] Method for producing human embryonic stem cell-derived perivascular progenitor cell and composition for cell therapy comprising the same (Registration number 10-1515369)
42 [KR] A screening method for the optimal surface structure of embryonic stem cell culture using a cell culture plate comprising gradient nanopattern (Registration number 10-1490671)